**5. Acknowledgments**

The authors gratefully acknowledge Dr. Reddy's Laboratory, Hyderabad, India for the gift sample of Carvedilol. The authors are thankful to AISSMS college of Pharmacy, Pune, India for providing FTIR and DSC facilities. Also the authors would like to thank Shivaji University, Kolhapur, India for providing PXRD facility.

Preparation of Carvedilol Spherical Crystals Having Solid Dispersion Structure

*Symposium Series*. 1991; 284, 26-32.

*Pharmaceutical. Education*, 36, 66-71.

Williams amd Wilkins, Baltimore.

Pharmaceutical Press, London, 2002, pp. 855-856.

method. *Research in Pharmaceutical Sciences*, 4, 77-84.

properties. *International Journal of Drug Delivery*, 2, 304-313.

1983; 34, 255-60.

4550(216), 1127-8.

27, 48-49.

3035.

Available from:

solutions.cfm?PrintAll=1.

by the Emulsion Solvent Diffusion Method and Evaluation of Its *in vitro* Characteristics 655

Kawashima Y, Lin SY, Ogawa M, Handa T, Takenaka H. Preparations of agglomerated

Kawashima Y, Naito M, Lin SY, Takenaka H. An experimental study of the kinetics of the

Kawashima Y, Okumura M, Takenaka H. Spherical crystallization: direct spherical

Kawashima Y, Okumura M, Takenaka H. The effects of temperature on the spherical

Kawashima Y, Takeuchi H, Niwa T, Hino T, Yamakoshi M, Kihara K. Preparation of

Kulkarni, P.K. and Nagavi B.G. (2002). Spherical crystallization. *Indian Journal of* 

Khan, K.A. (1975). The concept of dissolution efficiency. *Journal Pharmacy and Pharmacology*,

Marshall, P.V., York, P. (1991). Compaction Properties of Nitrofurantoin Samples

Martin, A., Bustamante, P., Chun, A. (2002). Micromeritics, In: *Physical Pharmacy- physical* 

Sano, A., Kuriki T., Kawashima Y., Takeuchi H., Hino T., and Niwa T. (1992). Particle design

Sweetman, S.C. (Ed(s).). (2002). *Martindale The Complete Drug Reference*. 33rd ed.,

Tapas, A.R., Kawtikwar, P.S., Sakarkar, D.M. (2009). Enhanced dissolution rate of felodipine

Tapas, A.R., Kawtikwar, P.S., Sakarkar, D.M. (2010). Spherically agglomerated solid

Usha, A.N., Mutalik, S., Reddy, M.S., Rajith, A.K., Kushtagi, P., Udupa, N. (2008).

http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp\_SearchResults\_Dis

crystallization of salicylic acid. *Powder Technol.* 1984; 39, 41-47.

the spherical crystallization technique. *J. Pharm. Sci.* 1985; 74, 1152-6. Kawashima Y, Morishima K, Takeuchi H, Niwa T, Hino T, Kawashima Y. Crystal design for

crystals of polymorphic mixtures and a new complex of indomethacin-epirizole by

direct tabletting and coating by the spherical crystallization technique. *AIChE* 

spherical crystallization of sodium theophylline monohydrate. *Powder Technol*.

agglomeration of salicylic acid crystals during crystallization. *Science*. 1982;

spherically agglomerated crystals of an antibacterial drug for direct tabletting by a novel spherical crystallization technique. *Congr. Int. Technol. Pharm.* 1989; 5, 228-34.

Crystallised from Different Solvents. *International Journal of Pharmaceutics*, 67, 59-65.

*chemical principles in the pharmaceutical sciences*, 4th ed., pp. 423-452, Lippincott

of tolbutamide by spherical crystallization technique. V. Improvement of dissolution and bioavailability of direct compressed tablets prepared using tolbutamide agglomerated crystals. *Chemical and Pharmaceutical. Bulletin*, 40, 3030-

using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion

dispersions of valsartan to improve solubility, dissolution rate and micromeritic

Preparation and in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. *European Journal of Pharmaceutics and Biopharmaceutics*, 70, 674-683. U.S. Food and drug administration [Internet]. Dissolution methods for drug products; 2010.

#### **6. References**


Anderson, N.H., Bauer, M., Boussac, N., Khan-Malek, R., Munden, P., Sardaro, M. (1998).

Bodmeier R., Paeratakul R. (1989). Spherical agglomerates of water-insoluble drugs. *Journal* 

Cui F., Yang M., Jiang Y., Cun D., Lin W., Fan Y., Kawashima Y (2003). Design of sustained-

emulsion solvent diffusion method. *Journal of ControlledRelease*, 91, 375-384. Di Martino, P., Barthelemy, C., Piva, F., Joiris, E., Palmieri, G.F., Martelli, S. (1999). Improved

Garekani, H.A., Ford, J.L., Rubinstein, M.H., Rajabi-Siahboomi, A.R. (1999). Formation and

Kawashima Y, Aoki S, Takenaka H. Spherical agglomeration of aminophylline crystals

Kawashima Y, Capes CE. Experimental study of the kinetics of spherical agglomeration in

Kawashima Y, Capes CE. Further studies of the kinetics of spherical agglomeration in a

Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. Improvements in flowability

Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. Parameters determining the

Kawashima Y, Furukawa K, Takenaka H. The physicochemical parameters determining the

Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. Improved flowability

Kawashima Y, Imai M, Takeuchi H, Yamamoto H, and Kamiya, K, Development of

crystallization with a 2 solvent system. *Powder Technol*. 1994; 78, 151-157. Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. Improved static compression

Paracetamol. *International Journal of Pharmaceutics*, 187, 77-89.

as stirred vessel. *Powder Technol.* 1974; 10, 85-92.

stirred vessel. *Powder Technol.* 1976; 13, 279-288.

miscible solvent systems. *Int. J. Pharm.* 1995; 119, 139-47.

An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. *Journal of Pharmaceutical and Biomedical Analysis,* 17, 811–822. Bhutani, S., Hiremath, S.N., Swamy, P.V., Raju, S.A. (2001). Preparation and evaluation of

inclusion complexes of carvedilol. *Journal of Scientific and Industrial Research*, 66, 830-

release nitrendipine microspheres having solid dispersion structure by quasi-

dissolution behavior of fenbufen by spherical crystallization. *Drug Delivery and* 

Compression Properties of Prismatic Polyhedral and Thin Plate-like Crystals of

during reaction in liquid by the spherical crystallization technique. *Chem. Pharm.* 

and compressibility of pharmaceutical crystals for direct tabletting by spherical

behaviors and tablettabilities of spherically agglomerated crystals produced by the spherical crystallization technique with a two-solvent system. *Pharma. Res*. 1995; 12,

agglomeration behavior and the micromeritic properties of spherically agglomerated crystals prepared by the spherical crystallization technique with

size of agglomerate prepared by the wet spherical agglomeration technique. *Powder* 

and compactibility of spherically agglomerated crystals of ascorbic acid for direct tabletting designed by spherical crystallization process. *Powder Technol*. 2003; 130,

Agglomerated Crystals of Ascorbic acid by the Spherical Crystallization Technique for Direct Tabletting, and Evaluation of their Compactibilities, *Kona*. 2002; 20, 251-261.

**6. References** 

834.

*of Pharmaceutical Sciences*, 78, 964-967.

*Industrial Pharmacy*, 25, 1073-1081.

*Bull.* 1982; 30, 1900-2.

*Technol.* 1981; 30, 211-16.

1040-4.

283-289.


 http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp\_SearchResults\_Dis solutions.cfm?PrintAll=1.

Wells, J. (2002). Pharmaceutical preformulation, the physicochemical properties of drug substances, In: *Pharmaceutics- the science of dosage form design*, M.E. Aulton (Ed), pp. 113-138, Churchill Livingstone, London.

Wells, J. (2002). Pharmaceutical preformulation, the physicochemical properties of drug

113-138, Churchill Livingstone, London.

substances, In: *Pharmaceutics- the science of dosage form design*, M.E. Aulton (Ed), pp.
